現在地

鍋倉 宰(ナベクラ ツカサ; Nabekura, Tsukasa)

所属
生存ダイナミクス研究センター
職名
助教
URL
eメール
 
電話
+81-29-853-3281
研究分野
免疫学
研究キーワード
Tumor immunology
Natural killer cells
Immunity
Bone marrow transplant
Hematology
Viral infection
研究課題
急性肝障害におけるグループ1自然リンパ球が発現するDNAM-1の役割2018-04 -- 2021-03The Naito Foundation/The Naito Grant for Fostering Scientific Full Bloom for the Next Generation
急性肝障害におけるDNAM-1の役割2018-04 -- 2020-03Kato Memorial Bioscience Foundation/Grant-in-Aid
急性肝障害におけるDNAM-1の役割2018-04 -- 2019-03Life Science Foundation of Japan/Grant-in-Aid
急性肝障害におけるDNAM-1 の役割2018-04 -- 2019-03The Uehara Memorial Foundation/Grant-in-Aid
急性肝障害におけるグループ1自然リンパ球が発現するDNAM-1の役割2018-04 -- 2019-03Kanae Foundation for the Promotion of Medical Science/The 46th Kanae grant
記憶ナチュラルキラー細胞分化におけるマスター制御因子の同定2017 -- 2019鍋倉 宰日本学術振興会/若手研究(A)24,310,000円
Identification of a master regulator of the differentiation of memory natural killer cells2017-04 -- 2019-03The Japan Society for the Promotion of Science/Grant-in-Aid for Young Scientists (A)
慢性骨髄性白血病の再発に対する同種MHC反応性記憶ナチュラルキラー細胞を用いた新規ドナー養子免疫療法の開発2015-04 -- 2016-03The Nakajima Foundation/Grant for Japanese young investigators
慢性骨髄性白血病再発に対するアロ反応性記憶ナチュラルキラー細胞を用いた 免疫療法の開発2014-04 -- 2015-03Friends of Leukemia Research Fund/Grant for young investigators
移植片対宿主病におけるDNAM-1の関与2009-04 -- 2011-03独立行政法人日本学術振興会/Grant-in-Aid for Young Scientists (Start-up)
職歴
2014-03 -- (現在)University of Tsukuba Life Science Center of TARA International Tenure-track Assistant Professor
2014-11 -- 2016-10University of California, San Francisco Department of Microbiology and Immunology, Lewis L. Lanier lab Specialist
2011-11 -- 2014-10University of California, San Francisco Department of Microbiology and Immunology, Lewis L. Lanier lab Postdoctoral Scholar
2008-04 -- 2011-10University of Tsukuba Graduate School of Comprehensive Human Sciences Postdoctoral fellow
学歴
2005-04 -- 2008-03University of Tsukub Graduate School of Comprehensive Human Sciences Doctoral Program in Advanced Biomedical Applications修了
取得学位
2008-03Ph.D.University of Tsukub
所属学協会
2012 -- (現在)American Association of Immunologists
2003 -- (現在)Japanese Society for Immunology.
受賞
2017-02BEST FACULTY MEMBER in University of Tsukuba
2017-12The Japanese Society of Immunology Young Investigator Award
2013-05AAI Trainee Abstract Award of IMMUNOLOGY 2013 Annual Meeting, The American Association of Immunologists
2012-11Postdoctoral Fellowship for Research Abroad of the Japan Society for the Promotion of Science (JSPS)
2011-11Postdoctoral Fellowship of the Uehara Memorial Foundation
2011-11Subsidy for Inter-Institute Researches of the Naito Foundation
2011-11Fellowship for Research Abroad of the Mochida Memorial Foundation for Medical and Pharmaceutical Research
2011-01Most Valuable Presenter in the 5th Tsukuba Medical Science Research Meeting
2011-01Best Paper Award in the 5th Tsukuba Medical Science Research Meeting
2008-04Research Fellowship for Young Scientists of the Japan Society for the Promotion of Science (JSPS), PD
2008-03Graduate with Summa Cum Laude (3-year graduation in 4-year Doctoral Course), University of Tsukuba
2007-04Research Fellowship for Young Scientists of the Japan Society for the Promotion of Science (JSPS), DC2
2006-01Cancer Research Fellowship for Graduate Students of Yasuda Medical Foundation
2005-03Best Paper Award in the Master’s Program in Medical Sciences, University of Tsukuba
2005-03Graduate with Summa Cum Laude (Best Paper Award in Master Course), University of Tsukuba
2003-03Graduate with Summa Cum Laude (Undergraduate Course), University of Tsukuba
論文
著書
  • An immunotherapy approach with dendritic cells genetically modified to express the tumor-associated antigen, HER2
    Nabekura Tsukasa
    2008-03
会議発表等
  • 活性化受容体NKG2D はマウスサイトメガロウイルス感染時のナチュラルキラー細胞の増殖を促進するが、NKG2D シグナル単独では増殖に不十分である
    鍋倉 宰
    第6回筑波大学・東京理科大学合同リトリート/2018-03-17
  • 自己MHCクラスIを認識する活性化NK細胞受容体はNK細胞のエフェクター機能と記憶細胞分化を促進する
    鍋倉 宰
    第9回血液・疾患免疫療法学会学術集会/2017-09-30
  • Tracking the fate of antigen-specific versus cytokine-activated natural killer cells after cytomegalovirus infection
    Nabekura Tsukasa
    The 46th Annual Meeting of the Japanese Society of Immunology/2017-12
  • 共刺激分子DNAM-1はサイトメガロウイルス感染時に於ける記憶ナチュラルキラー分化に必要である
    鍋倉 宰; 金谷 穣; 渋谷 彰; Guo Fu; Gascoigne Nicholas ...
    第9回血液・疾患免疫療法学会学術集会/2017-09-30
  • Establishment of a novel cancer immunotherapy with genetically modified dendritic cells.
    Nabekura Tsukasa
    The 33rd Annual Meeting of the Japanese Society for Immunology/2003-12
  • Feasibility of vaccine therapy with dendritic cells genetically modified to express the tumor-associated antigen HER2
    Nabekura Tsukasa
    The 11th Annual Meeting of the Japan Society of Gene Therapy/2005-07
  • Feasibility of vaccine therapy with dendritic cells genetically modified to express the tumor-associated antigen HER2
    Nabekura Tsukasa
    The 35th Annual Meeting of the Japanese Society for Immunology/2005-12
  • Feasibility of vaccine therapy with dendritic cells genetically modified to express the tumor-associated antigen HER2
    Nabekura Tsukasa
    The 12th Annual Meeting of the Japan Society of Gene Therapy/2006-08
  • Feasibility of vaccine therapy with dendritic cells genetically modified to express the tumor-associated antigen HER2
    Nabekura Tsukasa
    The 36th Annual Meeting of the Japanese Society of Immunology/2006-12
  • Feasibility of vaccine therapy with dendritic cells genetically modified to express the tumor-associated antigen HER2
    Nabekura Tsukasa
    The 13th Annual Meeting of the Japan Society of Gene Therapy/2007-06
  • An immunotherapy approach with dendritic cells genetically modified to express the tumor-associated antigen, HER2
    Nabekura Tsukasa
    The 37th Annual Meeting of the Japanese Society of Immunology/2007-11
  • Induction of tumor-specific T cells by inoculation of genetically modified dendritic cells
    Nabekura Tsukasa
    The 18th Kyoto T Cell Conference/2008-06
  • Novel prophylactic and therapeutic approaches to GVHD with a monoclonal antibody against DNAM-1
    Nabekura Tsukasa
    The 71st Annual Meeting of the Japanese Society of Hematology/2009-10
  • Novel prophylactic and therapeutic approaches to GVHD with a monoclonal antibody against DNAM-1
    Nabekura Tsukasa
    The 39th Annual Meeting of the Japanese Society of Immunology/2009-12
  • Novel prophylactic and therapeutic approaches to GVHD with a monoclonal antibody against DNAM-1
    Nabekura Tsukasa
    The 2nd Society of Immunotherapy for Hematological Malignancies/2010-08
  • A critical role of DNAM-1 in the development of acute graft-versus-host disease
    Nabekura Tsukasa
    The 5th Tsukuba Medical Science Research Meeting/2011-01
  • Natural killer cell licensing and tolerance modulate differentiation of natural killer cells during mouse cytomegalovirus infection
    Nabekura Tsukasa
    The 44th Annual Meeting of the Japanese Society of Immunology/2015-11
  • Potent cancer immunotherapy with dendritic cells generated from genetically modified hematopoietic stem cells
    Nabekura Tsukasa
    The 7th Annual Meeting of the American Society of Gene Therapy/2004-06
  • A critical role of DNAM-1 in the development of acute graft-versus-host disease
    Nabekura Tsukasa
    The Keystone Symposia on Molecular and Cellular Biology (Lymphocyte Activation)/2010-02
  • A critical role of DNAM-1 in the development of acute graft-versus-host diseas
    Nabekura Tsukasa
    The 14th International Congress of Immunology/2010-08
  • DNAM-1 is required for expansion of effector NK cells and generation of memory NK cells during mouse cytomegalovirus infection
    Nabekura Tsukasa
    IMMUNOLOGY 2013 AAI Annual Meeting at Honolulu/2013-05
  • Activating receptors for self-MHC class I enhance effector functions and memory differentiation of NK cells during mouse cytomegalovirus infection
    Nabekura Tsukasa
    第26回東京免疫フォーラム/2017-03
  • The role of CD155, a novel co-stimulatory molecule in CD4+ T cells, in contact dermatitis
    Yumi Kanemaru; Yuichi Takahashi; Yinan Wang; Aya Yoshioka...
    第40回 日本免疫学会総会・学術集会/2011-11
  • 活性化免疫受容体DNAM-1の急性肝GVHDの病態形成における重要な役割
    金谷 穣; 渋谷 和子; 阿部 史枝; 鍋倉 宰; 渋谷 彰
    第4回造血器腫瘍免疫療法研究会学術集会/2012-08-18
  • DNAM-1は移植片対宿主病の発症において重要な役割を果たす
    鍋倉 宰; 渋谷 和子; 竹中 江里; 渋谷 彰
    第20回Kyoto T Cell Conference/2010-06-05
知的財産権
  • 活性調節剤、これを含有する医薬品、および抗CD300a抗体
    渋谷 彰; 小田 ちぐさ; 田原 聡子; 鍋倉 宰; カンカーナム...
  • セリアック病に関連する、CD300a遺伝子欠損マウスおよびCD300a発現細胞の活性調節剤の使用、ならびにCD300a発現細胞の活性調節剤を含有する医薬品
    渋谷 彰; 小田 ちぐさ; 鍋倉 宰
  • Use of Celiac disease-associated CD300a gene-deficient mouse, activity modulator for CD300a-expressing cells, and medical and pharmaceutical agent comprising activity modulators for CD300a-expressing cells
    鍋倉 宰
  • A Method for Generation of Antibodies Using Genetically Modified Dendritic Cells by Vectors
    鍋倉 宰
  • Adoptive Gene and Cell Therapy with Immune Cells Genetically Modified by Retroviral Vectors
    鍋倉 宰
  • 活性調節剤、これを含有する医薬品、CD300a遺伝子欠損マウスの使用および抗CD300a抗体
    渋谷 彰; 小田 ちぐさ; 田原 聡子; 鍋倉 宰; カンカーナ...
担当授業科目
2017 -- 2017人間生物学I(科目番号:EB90011・秋AC)第5講 血液・感染・免疫生物学筑波大学
2017 -- 2017Phase I 医学の基礎(科目番号:HB31102・秋・集中)医学の基礎コース♯5免疫学筑波大学
2017 -- 2017医科学セミナーV(キャリアパス)(科目番号:01EQ042・通年)筑波大学
2017 -- 2017医科学英語論文講読の基礎(科目番号:HE24001・春・水曜1時限)ST2 amplifies NK cell expansion and enhances host defense during MCMV筑波大学
2017 -- 2017Research Presentation and Discussion(科目番号:02EW033・春・水2時限) ST2 amplifies NK cell expansion and enhances host defense during MCMV筑波大学
2017 -- 2017新しい基礎医学における神経科学と免疫研究(科目番号:1D21011・春・火曜1時限)ナチュラルキラー細胞が持つ適応免疫学的特性筑波大学
2016 -- 2016Phase I 医学の基礎(科目番号:HB31102・秋・集中)医学の基礎コース♯5免疫学筑波大学
2005 -- 2006“Hematology” course at University of Tsukuba, Japan, 2nd quarter in 2006 and 2005, as a teaching assistantUniversity of Tsukuba
授業以外の教育活動
2017 -- (現在)筑波大学大学院 人間総合科学研究科博士課程 生命システム医学専攻 担当教員資格認定筑波大学
2017 -- (現在)筑波大学大学院 人間総合科学研究科修士課程 フロンティア医科学専攻 担当教員資格認定筑波大学
学協会等委員
2019-04 -- 2022-03The Japanese Society for ImmunologyCouncilor
2017-04 -- 2018-03the 6th Retreat of Univ. of Tsukuba and Tokyo Univ. of ScienceManagement Secretariat
2017-04 -- 2018-03The Japanese Society for ImmunologyCooperation Committee Member
その他の活動
2017-08 -- 2017-08Menneki Fushigi Mirai 2017 (organized by Kenji Ishiwata, the Japanese Society for Immunology) at Tokyo, Japan.
2008-05 -- 2008-05Menneki Hushigi Mirai 2008 (organized by Masayuki Miyasaka, the Japanese Society for Immunology) at Tokyo, Japan
2008-04 -- 2008-04Menneki Town Meeting Tsukuba (organized by Akira Shibuya, the Japanese Society for Immunology) at Ibaraki, Japan.

(最終更新日: 2018-04-09)